Manulife (Manufacturers Life Insurance)
AVNS

Manulife (Manufacturers Life Insurance)’s Avanos Medical AVNS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$175K Sell
12,474
-2,477
-17% -$33.4K ﹤0.01% 2500
2025
Q4 		$168K Sell
14,951
-654
-4% -$7.48K ﹤0.01% 2592
2025
Q3 		$180K Sell
15,605
-1,329
-8% -$15.6K ﹤0.01% 2617
2025
Q2 		$207K Buy
16,934
+886
+6% +$11.1K ﹤0.01% 2546
2025
Q1 		$230K Sell
16,048
-5,983
-27% -$93.4K ﹤0.01% 2434
2024
Q4 		$351K Sell
22,031
-965
-4% -$19.1K ﹤0.01% 2389
2024
Q3 		$553K Buy
22,996
+5,859
+34% +$134K ﹤0.01% 2236
2024
Q2 		$341K Buy
17,137
+590
+4% +$11.5K ﹤0.01% 2361
2024
Q1 		$329K Sell
16,547
-6,391
-28% -$124K ﹤0.01% 2348
2023
Q4 		$514K Sell
22,938
-467
-2% -$9.64K ﹤0.01% 2155
2023
Q3 		$473K Buy
23,405
+4,737
+25% +$107K ﹤0.01% 2167
2023
Q2 		$477K Buy
18,668
+60
+0.3% +$1.58K ﹤0.01% 2065
2023
Q1 		$553K Buy
18,608
+74
+0.4% +$2.15K ﹤0.01% 1952
2022
Q4 		$502K Sell
18,534
-133
-0.7% -$3.25K ﹤0.01% 1989
2022
Q3 		$407K Sell
18,667
-307
-2% -$8.02K ﹤0.01% 2112
2022
Q2 		$519K Sell
18,974
-1,037
-5% -$29.8K ﹤0.01% 2034
2022
Q1 		$670K Sell
20,011
-4,733
-19% -$152K ﹤0.01% 1997
2021
Q4 		$858 Sell
24,744
-331
-1% -$10.7K ﹤0.01% 1934
2021
Q3 		$782K Sell
25,075
-1,823
-7% -$61.9K ﹤0.01% 1992
2021
Q2 		$978K Sell
26,898
-52,870
-66% -$2.19M ﹤0.01% 2011
2021
Q1 		$3.49M Sell
79,768
-5,588
-7% -$262K ﹤0.01% 1380
2020
Q4 		$3.92M Sell
85,356
-3,855
-4% -$160K ﹤0.01% 1314
2020
Q3 		$2.96M Sell
89,211
-2,213
-2% -$70.7K ﹤0.01% 1315
2020
Q2 		$2.66M Sell
91,424
-6,047
-6% -$175K ﹤0.01% 1325
2020
Q1 		$2.63M Buy
97,471
+3,036
+3% +$90.7K ﹤0.01% 1236
2019
Q4 		$3.18M Sell
94,435
-4,309
-4% -$156K ﹤0.01% 1303
2019
Q3 		$3.7M Sell
98,744
-6,674
-6% -$255K ﹤0.01% 1247
2019
Q2 		$4.6M Sell
105,418
-1,428
-1% -$61.1K 0.01% 1203
2019
Q1 		$4.56M Sell
106,846
-3,741
-3% -$168K ﹤0.01% 1237
2018
Q4 		$4.95M Buy
110,587
+3,325
+3% +$174K 0.01% 1135
2018
Q3 		$7.35M Buy
107,262
+107,250
+893,750% +$6.9M 0.01% 1055
2018
Q2 		$1K Sell
12
-107,946
-100% -$5.7M ﹤0.01% 4237
2018
Q1 		$4.97M Sell
107,958
-3,413
-3% -$162K 0.01% 1231
2017
Q4 		$5.14M Buy
111,371
+8,757
+9% +$402K 0.01% 1197
2017
Q3 		$4.62M Sell
102,614
-303
-0.3% -$12.9K 0.01% 1197
2017
Q2 		$4.04M Buy
102,917
+575
+0.6% +$21.7K ﹤0.01% 1257
2017
Q1 		$3.9M Buy
102,342
+8,349
+9% +$325K ﹤0.01% 1239
2016
Q4 		$3.48M Sell
93,993
-639
-0.7% -$22.8K 0.01% 1242
2016
Q3 		$3.28M Buy
94,632
+1,075
+1% +$37.7K ﹤0.01% 1255
2016
Q2 		$3.04M Buy
93,557
+2,268
+2% +$69.5K ﹤0.01% 1245
2016
Q1 		$2.67M Buy
91,289
+2,086
+2% +$55.6K ﹤0.01% 1323
2015
Q4 		$2.98K Sell
89,203
-44
-0% -$1.37K ﹤0.01% 1291
2015
Q3 		$2.54K Sell
89,247
-434
-0.5% -$15.1K ﹤0.01% 1311
2015
Q2 		$3.63K Buy
89,681
+29,586
+49% +$1.33M ﹤0.01% 1207
2015
Q1 		$2.96K Buy
60,095
+294
+0.5% +$13.6K ﹤0.01% 1274
2014
Q4 		$2.72K Buy
+59,801
New +$2.35M ﹤0.01% 1239

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AVNS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Avanos Medical (AVNS) stake by 17% in Q1 2026, selling an estimated $33.4K and leaving 12,474 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Manulife (Manufacturers Life Insurance) first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $7.35M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 12,474 shares of Avanos Medical worth $175K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,477 Avanos Medical shares in Q1 2026, an estimated $33.4K.
  • Avanos Medical made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2500 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Avanos Medical position peaked at $7.35M in Q3 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.